Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Faks

Explore full profile

An application linking pharmacy professionals, including pharmacies, groups, and laboratories

Paris, FranceFounded 2020Biotech & Life Sciences
Valuation $25–50M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Faks and the history behind them.

About Faks

Faks.co is a tech startup that operates in the financial technology (fintech) sector, specifically in the area of invoice management. The company has developed a user-friendly mobile application that simplifies the process of making claims and managing invoices. The app is designed to save time and improve efficiency for businesses, particularly those in the pharmaceutical sector.

Faks.co's primary clients are pharmacies, as evidenced by testimonials from pharmacists who have praised the app for its simplicity, time-saving capabilities, and potential for team-wide use. The app allows users to make claims in as little as 30 seconds and provides notifications when these claims are settled. It also offers a centralized location for archiving all invoices, making it easy for team members involved in order processing and invoice control to access necessary documents.

The business model of Faks.co is likely based on a software-as-a-service (SaaS) model, a common approach in the fintech sector. This means that clients pay a subscription fee to use the app, providing a steady stream of revenue for the company. The exact pricing structure is not specified, but it's common for such services to offer different tiers of pricing depending on the features and level of service required.

In conclusion, Faks.co is a promising fintech startup that offers a simple and efficient solution for invoice management, particularly for pharmacies. Its user-friendly app and SaaS business model position it well for growth in the expanding fintech market.

Source: Dealroom company data

At a glance

Founded
2020
Headquarters
Paris, France
Sector
Biotech & Life Sciences

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Super Capital
  • Connect Ventures (Europe)
  • Cocoa VC
  • Seedcamp

Series A2 investors entered at this stage

Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇫🇷 France90.6%
🇬🇧 United Kingdom6.3%
🇺🇸 United States3.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Faks on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Faks on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.